Viewing Study NCT05627960


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 7:11 PM
Study NCT ID: NCT05627960
Status: RECRUITING
Last Update Posted: 2022-11-28
First Post: 2022-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Sponsor: A&G Pharmaceutical Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module